cancer

IceCure’s FDA-cleared cryoablation system for breast cancer is gaining physician and patient traction, sending shares up more than 200% on heavy volume. Investorideas.com (www.investorideas.com) a go-to platform for big investing…

U.K. pharmaceutical giant GSK on Tuesday struck a $10.6 billion deal to buy U.S.-listed biotech company Nuvalent, its biggest acquisition in eight years as it seeks to bolster the cancer…

Metastatic breast cancer (MBC) remains incurable, with approximately only one-third of diagnosed women meeting the five year survival rate. Subtypes like triple-negative breast cancer (TNBC) or heavily pretreated hormone receptor-positive…

An experimental drug that could be a breakthrough in the treatment of one of the deadliest known cancers is driving demand at clinics while awaiting full government approval. Daraxonrasib, a…

Invion’s (ASX:IVX,OTC Pink:IVIXF) Photosoft cancer treatment technology has entered an important milestone, thanks to a new collaboration deal with Taiwanese firm Protect Animal Health, to undertake studies to treat cancer…

Skin Analytics, a HealthTech company focused on building a future where “nobody dies of skin cancer”, has secured €17.5 million in Series B funding led by Intrepid Growth Partners in…

I have a member in my Financial Independence community who was diagnosed with blood cancer in 2023. He has since undergone treatments and we are happy that he is currently…

“I am pretty much uninsurable.”